Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study

Jessica D. Johnson, Salvador Alejo, Sridharan Jayamohan, Gangadhara R. Sareddy

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Introduction: Lysine-specific histone demethylase 1A (KDM1A/LSD1) has emerged as an important therapeutic target in various cancer types. LSD1 regulates a wide range of biological processes that influence cancer development, progression, metastasis, and therapy resistance. However, recent studies have revealed novel aspects of LSD1 biology, shedding light on its involvement in immunogenicity, antitumor immunity, and DNA damage response. These emerging findings have the potential to be leveraged in the design of effective LSD1-targeted therapies. Areas covered: This paper discusses the latest developments in the field of LSD1 biology, focusing on its role in regulating immunogenicity, antitumor immunity, and DNA damage response mechanisms. The newfound understanding of these mechanisms has opened possibilities for the development of novel LSD1-targeted therapies for cancer treatment. Additionally, the paper provides an overview of LSD1 inhibitor-based combination therapies for the treatment of cancer. Expert opinion: Exploiting LSD1 role in antitumor immunity and DNA damage response provides cues to not only understand the LSD1-resistant mechanisms but also rationally design new combination therapies that are more efficient and less toxic than monotherapy. The exploration of LSD1 biology and the development of LSD1-targeted therapies hold great promise for the future of cancer treatment.

Original languageEnglish (US)
Pages (from-to)1177-1188
Number of pages12
JournalExpert opinion on therapeutic targets
Issue number12
StatePublished - 2023


  • antitumor immunity
  • combination therapies
  • DNA damage response
  • DNA repair
  • epigenetics
  • immune therapies
  • LSD1/KDM1A

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry


Dive into the research topics of 'Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study'. Together they form a unique fingerprint.

Cite this